General Information of DTT (ID: TTA7UJC)

DTT Name Alpha-1-antitrypsin (SERPINA1) DTT Info
Gene Name SERPINA1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
2 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Glassia DM83MOK Emphysema CA21 Approved [1]
Zemaira DMA5QPM Emphysema CA21 Approved [2]
------------------------------------------------------------------------------------
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
AGTC-0106 DMMKASG Alpha-1 antitrypsin deficiency 5C5A Phase 2 [3]
Igmesine DMH97XA Major depressive disorder 6A70.3 Phase 2 [4]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
2-Sulfhydryl-Ethanol DMJBO3D Discovery agent N.A. Investigative [5]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Mullard A: 2010 FDA drug approvals. Nat Rev Drug Discov. 2011 Feb;10(2):82-5.
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services.
3 First gene therapy nears landmark European market authorization. Nat Biotechnol. 2012 Sep;30(9):807-9.
4 Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin Emerg Drugs. 2006 May;11(2):275-91.
5 DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41.